Increased Exposure to PFAS, Phenols, and Parabens Linked to Prior Cancer Diagnosis
Higher exposure to PFAS, phenols, and parabens is associated with previous cancer diagnosis in women but not men, a study suggests.
Higher exposure to PFAS, phenols, and parabens is associated with previous cancer diagnosis in women but not men, a study suggests.
Diagnoses of in situ and invasive melanoma were stable from 2018 to 2019 but decreased from 2019 to 2020, researchers found.
Cancer patients with ICI-induced acute pancreatitis may require abdominal imaging for diagnosis and monitoring for exocrine pancreatic insufficiency.
Metastatic melanoma patients at the highest risk of death are more likely than lower-risk patients to receive immunotherapy near the end of their life.
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Patients with advanced melanoma who receive T-VEC prior to surgery have better long-term outcomes than patients treated with surgery alone, updated data suggest.
The Hepzato Kit (melphalan/hepatic delivery system) is approved as a liver-directed treatment for adults with metastatic uveal melanoma and unresectable hepatic metastases.
Adding binimetinib to treatment with encorafenib improves efficacy in patients with BRAFV600-mutant melanoma, new research confirms.
The prevalence of TERT promoter mutations among patients with cancer differs by race and sex, a large study suggests.
Patterns of melanoma presentation, disease severity, and mortality vary by race among men, a study suggests.